GB202008248D0 - Hybrid Antibody - Google Patents
Hybrid AntibodyInfo
- Publication number
- GB202008248D0 GB202008248D0 GBGB2008248.3A GB202008248A GB202008248D0 GB 202008248 D0 GB202008248 D0 GB 202008248D0 GB 202008248 A GB202008248 A GB 202008248A GB 202008248 D0 GB202008248 D0 GB 202008248D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hybrid antibody
- antibody
- hybrid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2008248.3A GB202008248D0 (en) | 2020-06-02 | 2020-06-02 | Hybrid Antibody |
CA3152097A CA3152097A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
JP2022520761A JP2022550976A (en) | 2019-10-01 | 2020-10-01 | hybrid antibody |
JP2022520650A JP2022552805A (en) | 2019-10-01 | 2020-10-01 | hybrid antibody |
CN202080083349.XA CN114761087A (en) | 2019-10-01 | 2020-10-01 | Hybrid antibodies |
PCT/EP2020/077609 WO2021064153A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
CA3152084A CA3152084A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
PCT/EP2020/077608 WO2021064152A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
US17/764,854 US20220380482A1 (en) | 2019-10-01 | 2020-10-01 | IgE Antibody with FcRn binding |
CN202080082725.3A CN115175736A (en) | 2019-10-01 | 2020-10-01 | Hybrid antibodies |
BR112022006364A BR112022006364A2 (en) | 2019-10-01 | 2020-10-01 | HYBRID ANTIBODY |
EP20789871.9A EP4041397A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
US17/764,850 US20230059181A1 (en) | 2019-10-01 | 2020-10-01 | IgE Antibody with Fcgamma Receptor binding |
AU2020360962A AU2020360962A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
EP20789872.7A EP4041398A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
MX2022004073A MX2022004073A (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody. |
KR1020227009817A KR20220070215A (en) | 2019-10-01 | 2020-10-01 | hybrid antibody |
AU2020358898A AU2020358898A1 (en) | 2019-10-01 | 2020-10-01 | Hybrid antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2008248.3A GB202008248D0 (en) | 2020-06-02 | 2020-06-02 | Hybrid Antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202008248D0 true GB202008248D0 (en) | 2020-07-15 |
Family
ID=71526420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2008248.3A Ceased GB202008248D0 (en) | 2019-10-01 | 2020-06-02 | Hybrid Antibody |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202008248D0 (en) |
-
2020
- 2020-06-02 GB GBGB2008248.3A patent/GB202008248D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI3872091T1 (en) | Antibodies against sars-cov-2 | |
IL308741A (en) | Anti-sirp-alpha antibodies | |
IL311043A (en) | Anti-il-11rα antibodies | |
IL300142A (en) | ANTI-IL13Ralpha2 ANTIBODIES | |
GB202105110D0 (en) | Anti-CD73 antibodies | |
GB202015115D0 (en) | ZIP12 Antibody | |
GB202014851D0 (en) | SARS-COV-2 antibodies | |
GB202008248D0 (en) | Hybrid Antibody | |
GB201917059D0 (en) | Hybrid antibody | |
GB201914165D0 (en) | Hybrid antibody | |
IL304741A (en) | Hybrid aav-anellovectors | |
EP4342989A4 (en) | Anti-norovirus antibody | |
GB202106027D0 (en) | Antibody | |
GB202105933D0 (en) | Anti-IL1rap antibody | |
GB202014969D0 (en) | ZIP12 antibody | |
IL310245A (en) | Anti-hla-g antibodies | |
GB202208773D0 (en) | Anti-SARS2-S antibodies | |
IL308782A (en) | Antibodies | |
IL308100A (en) | Antibodies | |
IL307175A (en) | Il-38-specific antibodies | |
GB202116709D0 (en) | Antibodies | |
GB202115824D0 (en) | Antibodies | |
GB202112297D0 (en) | Antibodies | |
IL299767A (en) | Anti-αlpha-4-βeta-7 antibodies | |
GB202107517D0 (en) | Antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |